PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of th
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field.
CMR Surgical strengthens senior team
CMR Surgical, the global surgical robotics business, announces the appointment of Markus Bauman as Chief Legal & Business Affairs Officer, joining the Company’s executive leadership team.
Natural probiotic discovered in UK newborns' microbiomes
Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalised infant therapeutic probiotics, researchers show.
Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development
Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as pa
ARU vision research shortlisted for national awards
Anglia Ruskin University nominated in two categories by Times Higher Education.
Qkine expands senior leadership
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer.
Unlocking opportunities in China's thriving Life Sciences market
As the second-largest healthcare market in the world, China is on an extraordinary trajectory of growth, with its life sciences sector expected to triple in size by 2030. This is an exciting time for UK life science companies looking to expand their horizons. Excellence First Enterprise Consultancy Ltd (EFEC) specialise in providing in2China services, designed specifically for UK firms eager to…
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applicationsDublin, Ireland, and Cheshire, UK: ERS Genomics Limited, the CRISPR licensing Company, and Medicines Disco
From farms to factories: patient journey to Pulmonary Fibrosis
Rosemary’s health journey has been anything but straightforward. After enduring three years of painful breathing tests with countless visits to her GP and specialist consultants, she was finally given a diagnosis 12 months later—a name that escaped her when her granddaughter asked.
Sapio Sciences advances the world's first AI-powered lab assistant
Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations
Nxera Pharma to receive US$35 Million from Neurocrine Biosciences upon positive phase 2 data for partnered Schizophrenia candidate NBI-1117568
Tokyo, Japan and Cambridge, UK - Nxera Pharma Co., Ltd. - formerly known as Sosei Group or Sosei Heptares – announces it will receive a US$35 million payment from Neurocrine Biosciences, triggered by the successful completion of the Phase 2 trial with NBI-1117568 (NBI-‘568) in adults with schizophrenia, as announced on 28 August 2024. Receipt of the US$35 million payment will be recognized as one…
Milner Therapeutics Institute 2024 symposium visual branding
I've been visual branding for the Milner Therapeutics Institute symposium since 2016 and designed the Milner Therapeutics Institute logo and built the original website (now in the hands of Nikki). I've been lucky to work each year with the team to develop their event branding.
eg technology launch EU office as they partner with Galway-based PorterShed
eg technology is pleased to announce our partnership with PorterShed in Galway, Ireland, as we open our first office directly servicing the EU market.
Hospice nurses awarded for their outstanding care in the community
Nurses, Michaela Hill, Gemma Powell and Sarah Pake receive a Cavell Trust Award.
Improving patient access to medicines targeting early-stage cancers in Europe
This article was published in ISPOR Value and Outcomes Spotlight
Innovate Cambridge appoints Kathryn Chapman to lead mission to amplify world-leading innovation ecosystem
Kathryn Chapman, previously Innovation Director at Babraham Research Campus will build on the success of Tabitha Goldsmith to lead Innovate Cambridge, the body responsible for increasing the UK city’s innovation and tech impact, building on the success of Tabitha Goldstaub After a decade of life sciences research and development, Chapman has spent over 15 years in strategic and leadership…
Who is looking after your Cyber Security?
Breathe Technology writes: We recently assisted a Cambridgeshire-based organisation that was the victim of a cyber attack. The systems were offline down for nearly a week and took almost a month to fully recover. They had security systems and backups in place. Or so they believed.
First MRI Wrapped Scanner in UK - at Addenbrooke's in Cambridge - will help save patients' lives and thousands of pounds in healthcare costs
Going for an MRI scan can be a daunting experience for some patients but the simple act of wrapping a scanner in nature-themed vinyl designs has had some far-reaching consequences. Read on to find out more...
Nxera Pharma notes positive topline results from its Phase 2 clinical study in adults with schizophrenia
Tokyo, Japan and Cambridge, UK - Nxera Pharma Co., Ltd. – formerly known as Sosei Group or Sosei Heptares – notes the announcement by its partner Neurocrine Biosciences Inc., that NBI-1117568 (NBI-‘568) has delivered positive topline results from its Phase 2 clinical study in adults with schizophrenia. NBI-’568 is the first investigational, oral, muscarinic M4 selective agonist in development for…
Dr Xand takes a visit to the BioResource laboratory
D-CYPHR ambassador checked out the exciting new technology used to decode the DNA provided by our volunteers.
Black Internship Programme 2024
For a fourth year running we have had the pleasure of hosting two interns over summer to gain hands-on experience in the Data Team at the NIHR BioResource. Proud to participate as one of HDR UK’s host organisation, the Black Internship Programme offers talented early career Black data scientists the opportunity to kickstart their health data science careers!
Transforming Healthcare: Navigating medical device regulations for startup success
In this episode we dive into medical device regulations with Sam Shelley, Quality Manager Consultant.